Q1 2023 Hypera SA Earnings Call Transcript
Good morning, ladies and gentlemen. Welcome to Hypera Pharma's Q1 2023 Earnings Conference. Joining us today are the company's CEO, Mr. Breno Oliveira; and its IRO, Mr. Adalmario Couto. We'd like to inform you that this event is being recorded and will be available for playback at the company's Investor Relations website, ri.hypera.com.br. (Operator Instructions)
Before we move on, we'd like to underscore that the information shared during this conference may include projections or forward-looking statements. Such information is subject to known and unknown risks and uncertainties that may cause such statements to not materialize or ultimately prove to be materially different than expected.
I will now hand over to Mr. Breno Oliveira, who will start the presentation. Mr. Oliveira, please proceed.
Good morning, everyone. Welcome to our Q1 2023 earnings conference. We'd like to start the presentation by talking about our growth, which is highlighted on Slide 3. We achieved 5.9%
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |